Nanoemulsion of myricetin enhances its anti-tumor activity in nude mice of triple-negative breast cancer xenografts
Similar to our earlier observation in <i>in-vitro</i> TNBC model, findings in the present study highlights that nanoemulsion of myricetin potentiates its anti-tumor activity in TNBC xenografts and provide a promising drug delivery strategy for better clinical outcomes.
Authors
- Mohammad Ahmed Khan (ORCID: https://orcid.org/0000-0002-7401-3299)
- Abul Kalam Najmi (ORCID: https://orcid.org/0000-0002-9299-414X)
- Preeti Sharma (ORCID: https://orcid.org/0000-0002-0113-6423)
- Shubhra Chaturvedi (ORCID: https://orcid.org/0000-0003-0285-2111)
- Yogesh Rai
- Anant Narayan Bhatt (ORCID: https://orcid.org/0000-0001-5157-9719)
- Mohd Akhtar (ORCID: https://orcid.org/0000-0002-3333-2672)
- Anil Kumar Mishra (ORCID: https://orcid.org/0000-0002-7451-4683)
Institutions
- Indian Institute of Technology Roorkee (IN)
- Jamia Hamdard (IN)
- Institute of Nuclear Medicine & Allied Sciences (IN)
- Defence Institute of Physiology and Allied Sciences (IN)
Publication Details
- Journal
- Frontiers in Oncology
- Published
- 2025-06-09
- DOI
- https://doi.org/10.3389/fonc.2025.1563076
- Citations
- 2
- Primary Topic
- Computational Drug Discovery Methods
- Type
- article
- Field-Weighted Citation Impact
- 3.01